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ABSTRACT Lynn Margulis in the 1960s elegantly proposed a shared phylogenetic
history between bacteria and mitochondria; this relationship has since become a
cornerstone of modern cellular biology. Yet, an interesting facet of the interaction
between the microbiome and mitochondria has been mostly ignored, that of the
systems biology relationship that underpins host health and longevity. The mito-
chondria are descendants of primordial aerobic pleomorphic bacteria (likely genus
Rickettsia) that entered (literally and functionally) into a mutualistic partnership with
ancient anaerobic microbes (likely Archaea). A stable symbiosis was established,
given the metabolic versatility of the early mitochondria, which were capable of pro-
viding energy with or without oxygen, whereas nutrient gathering was the assumed
responsibility of the host. While microbial relationships with single-cell protists must
have occurred in the past, as they occur today, the evolution of multicellular organ-
isms generated a new framework for symbiosis with the microbial world, taking the
ancient partnership to an entirely new level. Cell-cell communication between mi-
crobes and single-cell protists was augmented through multicellularity to allow dis-
tant communication between the host cells and the microbiome, resulting in the de-
velopment of complex metabolic relationships and an immune system to manage
these interactions. Thus, the host is now the body and its resident mitochondria,
and the microbiome is an essential supplier of metabolites that act at the level of
mitochondria in skeletal muscle to stabilize host metabolism. We humans are care-
takers of a profoundly vast and diverse microbiota, the majority of which resides in
the gut. Indeed, the microbial genetic diversity of our microbiota outstrips our own
by several orders of magnitude, and the cellular abundance is roughly equivalent to
our somatic selves. Modern clinical science has elegantly highlighted the importance
of the microbiome for metabolic health and well-being. This perspective underscores
one fundamental facet of this symbiosis, the ancestral mitochondrion-microbiome
axis.
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Nutrient metabolism is a function shared by both the microbiome and mitochon-dria. In recent years, it has become increasingly evident that the gut microbiome
produces metabolites that inﬂuence mitochondrial function and biogenesis (i.e., mito-
chondrial replication within a cell to increase ATP production). Recent studies have
highlighted the importance of three key microbiome metabolites: (i) the short-chain
fatty acids (SCFA), (ii) the urolithins, and (iii) lactate. In particular, among these key
metabolites is the SCFA butyrate, which is produced by microbial fermentation of
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indigestible ﬁber by a number of different bacterial lineages, including the Clostridium
and Butyrivibrio genera (1–3), and urolithin A, which is produced by lactobacilli and
Biﬁdobacterium from ellagitannins present in certain fruits, berries, and nuts (4, 5). Both
urolithin A and butyrate have been shown to enhance microbial diversity, as well as
promoting the abundance of bacteria that generate these compounds (5). In parallel,
SCFAs are known to activate AMP kinase, which might serve to induce mitochondrio-
genesis, revealing an alternative systemic limb of the interrelationship (6). As a mito-
chondrial energy source, butyrate is able to rescue respiratory depression of colono-
cytes in germfree mice (3). It is thus not surprising that the same bacteria that generate
these compounds are also able to confer resistance to metabolic disturbance (6). A link
between SCFA-producing and urolithin A-producing bacteria exists in lactic acid me-
tabolism, whereby the lactic acid produced by lactobacilli and biﬁdobacteria (and
possibly mitochondria) supports the production of butyrate from SCFA-producing
microbes (e.g., clostridia), accompanied by the production of ATP (7–9). There are
therefore explicit and implicit interactions between lactobacilli, biﬁdobacteria, SCFA-
producing bacterial strains, and the metabolites they produce that have broad systemic
metabolic ramiﬁcations if the correct tissues are targeted.
Metabolic health and mitochondrial health are synonymous. Mitochondria are our
predominant site of substrate oxidation. Muscle represents, proportionately, our largest
tissue mass and hence our greatest uniﬁed site of mitochondria, as well as one of our
most metabolically active tissues. Both mitochondrion and muscle functions are posi-
tively impacted by physical activity and diet. An obvious systems biology link couples
muscle health to microbial activity, and vice versa. On the one hand, the host’s ﬁtness
level correlates with higher fecal butyrate levels (2, 7, 10) as well as an increase in the
fecal concentration of Clostridium spp. and lactobacilli (6, 11–14). On the other hand,
both butyrate (15) and urolithin A (16, 17) enhance skeletal muscle’s oxidative capacity
and mitochondrial function. These results corroborate a muscle-microbiome reinforce-
ment from either direction.
Of particular interest, probiotic supplementation with Lactobacillus plantarum
(TWK10) exerts potent effects over muscle performance and oxidative capacity (8) as
well as an increase in colonic SCFA content (10). Skeletal muscle activity, via its capacity
to release myokines that quench systemic inﬂammation, increase fatty acid oxidation,
and promote mitochondriogenesis, also promotes microbiome diversity (6, 18). Bu-
tyrate and urolithin A may thus act synergistically at the level of the mitochondrion and
by mere virtue of muscle’s sheer predominance preferentially inﬂuence muscle function
and enhancement of systemic metabolism, strengthening the muscle-microbiome
bond. Although speculative, existing evidence also links muscular lactic acid production
to microbiome function, possibly even extending to components of the microbiome
outside the gut to reinforce and broaden this dynamic interaction. Indeed, an increased
relative abundance of lactobacilli (6, 12–14) and Clostridiaceae following exercise is
positively correlated with blood lactate accumulation, which reﬂects ﬁtness levels (14,
19). These results raise the provocative possibility of targeting muscle for systemic
metabolic improvement via speciﬁc nutritional intervention aimed at the microbiome.
The ability of speciﬁed microbiome lactobacilli to metabolize polyphenols found in
certain fruits (16) or fermented soy (8), which work in concert with SCFAs such as
butyrate (10, 20) to enhance muscle oxidative capacity by stimulating mitochondria,
can potentially be exploited to produce a form of metabolic stabilization somewhat
reminiscent of that exerted by physical activity. Finally, as advanced age is associated
with both muscle loss (sarcopenia) and microbiome dybiosis, such a therapeutic
approach holds the potential of slowing the onset of several metabolic and structural
deﬁcits inﬂicted by aging in elderly people.
The potential for precise therapeutic interventions that target microbial-mitochondrial
metabolic communication provides a novel avenue for the treatment of many metabolic
disturbances and could have profound implications for the future of medical treatments.
From an ancient union, the dominance of the microbial world is redeﬁning our perspective
for health and wellness.
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